Sheffield Hallam University
Sheffield, South Yorkshire, S1 1WB, United Kingdom
NCT Number: NCT02473575
The purpose of this study is to determine whether caffeine gum improves the performance of runners completing free timed mass participation 5 km runs in the United Kingdom (UK)
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Sheffield, South Yorkshire, S1 1WB, United Kingdom
The study will investigate the ability of an acute intake of caffeine gum to improve performance in recreationally trained runners completing park runs. Park runs are free, timed 5 km mass participation running events that are held in a number of parks around the UK every Saturday morning.
A total of 60 recreationally trained runners will be recruited to the study. Of these, 30 will be assigned to a randomised placebo-controlled double-blind cross-over trial. The remaining 30 will be assigned to a non-intervention comparison group. The non-intervention group will be used to account for the effect of changing environmental conditions on running performance.
All participants will complete two 5 km park runs separated by no more than 2 weeks. Participants on the intervention study arms will consume either caffeine or placebo gum 30 minutes before they run. The order of consumption will be randomised. The caffeine gum will contain 300 mg (with an approximate 85% bioavailability). Participants will be asked to abstain from any caffeine containing beverages or food for 18 hours before each run. They will also be asked to record their dietary intake for the day before and the morning of the run and to repeat this for their second trial. Physical activity on the days leading up to each 5 km run will also be recorded and participants will be asked to closely replicate their activity in the week leading up to each trial. They will also be asked to keep training intensity and duration light during the 48 hours leading up to each trial.
The primary outcome measure will be change in overall time for the 5 km runs. Other outcome measures will be ratings of perceived exertion, 1 km split times and average heart rate.
The study size was calculated using an online software package (http://www.sportsci.org/resource/stats/), adopting a power of 80% and an alpha of 0.05. Using within-person standard deviation from runners completing a local parkrun and an expected effect size of 1.2% (Bridge and Jones (2006) J Sports Sciences. 24(4):433-9) a sample size of 25 runners was calculated for the intervention study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Gum is consumed 30 minutes before commencement of run
Gum is consumed 30 minutes before commencement of run
Time frame: calculated after 2nd run (runs separated by 7 days)
The difference in finishing time on placebo v caffeine; recorded in seconds
Time frame: calculated after 2nd run (runs separated by 7 days)
The difference in RPE on placebo v caffeine; using a 6-20 Borg scale
Time frame: calculated after 2nd run (runs separated by 7 days); placebo v caffeine
1 km split times in sec will be recorded manually and overall pace using GPS (km/h)
Time frame: calculated after 2nd run
Recorded in beats per minute
Sheffield Hallam University
Other
Does a Commercial Caffeine Supplement Improve 5 km Run Performance in a Field Setting?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07565168
Endurance Exercise, Exercise Physiology
Fuenlabrada, Madrid, Spain
View Trial DetailsNCT03400761
Body Composition, Running Performance
View Trial DetailsNCT02401152
Gastric Distress, Running Performance
Arnhem, Gelderland, Netherlands
View Trial DetailsNCT07498608
Behavior, Motor Activity
Bogotá, Bogota D.C., Colombia
View Trial Details